Expression of dopamine receptors in the subthalamic nucleus of the rat: Characterization using reverse transcriptase-polymerase chain reaction and autoradiography

Neuroscience

Volumn 91, Issue 2, 1999, Pages 549-556

  Flores, G ^a,b   Liang, J J ^b   Sierra, A ^c   Martinez Fong D ^c   Quirion, R ^b   Aceves, J ^c   Srivastava, L K ^b  

^a BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

^b MCGILL UNIVERSITY   (Canada)

^c Biofis y Neurociencias   (Mexico)

Author keywords

6 hydroxydopamine; Basal ganglia; Caudate putamen; Dopamine transporter; Parkinson's disease; Substantia nigra

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXY 1,2,3,4 TETRAHYDRONAPHTHALENE; 3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; EMONAPRIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BASAL GANGLION; BINDING SITE; CELL ACTIVITY; ENZYME ACTIVITY; MALE; NERVE CELL; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; AUTORADIOGRAPHY; BENZAMIDES; DOPAMINE ANTAGONISTS; MALE; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RECEPTORS, DOPAMINE D4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TETRAHYDRONAPHTHALENES; THALAMIC NUCLEI; TRITIUM;

EID: 0032960185     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00633-2     Document Type: Article

References (53)

1. Abarca J., Gysling K., Roth R.H., Bustos G. Changes in extracellular levels of glutamate and aspartate in rat substantia nigra induced by dopamine receptor ligands: in vivo microdialysis study. Neurochem. Res. 20:1995;159-169.
2. Albin R.L., Young A.B., Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci. 12:1989;366-375.
3. Amara S.G., Kuhar M.J. Neurotransmitter transporters: recent progress. A. Rev. Neurosci. 16:1993;73-93.
4. Bergman H., Wichmann T., DeLong M. Reversal of experimental Parkinsonism by lesions of the subthalamic nucleus. Science. 249:1990;1436-1438.
5. Boja J. W., Vaughan R. A., Patel A., Shaya E. and Kuhar M. J. (1994) The dopamine transporter. In Dopamine Receptors and Transporters: Pharmacology, Structure, and Function (ed. Niznik H. B.), pp. 611-644. Marcel Dekker, New York.
6. 125I]iodosulpiride. Synapse. 19:1995;1-13.
7. 125I]iodosulpiride. Neuroscience. 20:1987;117-155.
8. 2 receptor mRNA. Brain Res. 564:1991;203-219.
9. Boyson S.J., McGonigle P., Molinoff P.B. Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain. J. Neurosci. 6:1986;3177-3188.
10. 2 dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. J. Pharmac. exp. Ther. 240:1987;167-176.
11. Brown L.I., Makman M.H., Wolfson L.L., Dvorkin B., Warner C., Katzman R. A direct role of dopamine in the rat subthalamic nucleus and an adjacent intrapeduncular area. Science. 206:1979;1416-1418.
12. 2 dopamine receptor cDNA. Nature. 336:1988;783-787.
13. Campbell G.A., Eckardt M.J., Weight F. Dopaminergic mechanisms in subthalamic nucleus of rat: analysis using horseradish peroxidase and microiontophoresis. Brain Res. 333:1985;261-270.
14. Carpenter M.B., Carleton S.C., Keller J.T., Conté P. Connections of the subthalamic nucleus in the monkey. Brain Res. 224:1981;1-29.
15. Creese L., Burt D.R., Snyder S.H. Dopamine receptors binding enhancement accompanies lesion-induced behavioral supersensitivity. Science. 197:1977;596-598.
16. DeLong M.R. Primate model of movement disorders of basal ganglia origin. Trends Neurosci. 13:1990;281-285.
17. Duncan G., Criswell H., McCown T.J., Paul L., Mueller R.A., Breese G.R. Behavioral and neurochemical response to haloperidol and SCH-23390 in rats treated neonatally or as adults with 6-hydroxydopamine. J. Pharmac. exp. Ther. 243:1987;1027-1034.
18. Floran B., Aceves J., Sierra A., Martínez-Fong D. Activation of D1 dopamine receptors stimulates the release of GABA in the basal ganglia of the rat. Neurosci. Lett. 116:1990;136-140.
19. Flores G., Valencia J., Rosales M.G., Sierra A., Aceves J. Appearance of EMG activity and motor asymmetry after unilateral lesions of the dopaminergic innervation to the subthalamic nucleus in the rat. Neurosci. Lett. 162:1993;153-156.
20. 3 receptors in limbic subregions following neonatal bilateral lesion of rat hippocampus. J. Neurosci. 16:1996;2020-2026.
21. 2 receptors in postpubertal rats after neonatal excitotoxic lesions of the medial prefrontal cortex. J. Neurosci. 16:1996;7366-7375.
22. 1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission. Proc. natn. Acad. Sci. U.S.A. 88:1991;3772-3776.
23. Gingrich J.A., Caron M.G. Recent advances in the molecular biology of dopamine receptors. A. Rev. Neurosci. 16:1993;299-321.
24. 3 dopamine receptor produced through various patterns of alternative splicing. Biochem. biophys. Res. Commun. 176:1991;1584-1592.
25. Gordon I., Weizman R., Rosenne E., Rehavi M. Developmental and age-related alterations in rat brain presynaptic dopaminergic mechanisms. Devl Brain Res. 85:1995;225-228.
26. 1 receptor supersensitivity. I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathways in the rat. Brain Res. 514:1990;93-102.
27. Hassani O.K., Francois C., Yelnik J., Feger J. Evidence for a dopaminergic innervation of the subthalamic nucleus in the rat. Brain Res. 749:1997;88-94.
28. Hazrati L., Parent A. Convergence of subthalamic and striatal efferents at pallidal level in primates: an anterograde double-labeling study with biocytin and PHA-L. Brain Res. 569:1992;336-340.
29. Hazrati L., Parent A. Differential patterns of arborization of striatal and subthalamic fibers in two pallidal segments in primates. Brain Res. 598:1992;311-315.
30. Horn A.S. Dopamine uptake: a review of progress in the last decade. Prog. Neurobiol. 34:1990;387-400.
31. Johnson A.E., Coirini H., Kallstrom L., Wiesel F.A. Characterization of dopamine receptor binding sites in the subthalamic nucleus. NeuroReport. 5:1994;1836-1838.
32. Kreiss D.S., Anderson L.A., Walters J.R. Apomorphine and dopamine D1 receptor agonists increase the firing rates of subthalamic nucleus neurons. Neuroscience. 72:1996;836-876.
33. Kreiss D.S., Mastropietro C.W., Rawji S.S., Walters J.R. The response of subthalamic nucleus neurons to dopamine receptor stimulation in a rodent model of Parkinson's disease. J. Neurosci. 17:1997;6807-6819.
34. 3H]hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc. natn. Acad. Sci. U.S.A. 89:1992;8155-8159.
35. 3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons. Proc. natn. Acad. Sci. U.S.A. 92:1995;1719-1723.
36. 1 receptor binding and mRNA in the rat brain using receptor autoradiographic and in situ hybridization techniques. Neuroscience. 45:1991;359-371.
37. Meibach R.C., Katzman R.C. Catecholaminergic innervation of the subthalamic nucleus: evidence for a rostral continuation of the A9 (substantia nigra) dopaminergic cell group. Brain Res. 173:1979;364-368.
38. Mintz I., Hammond C., Féger J. Excitatory effects of iontophoretically applied dopamine on identified neurons of the rat subthalamic nucleus. Brain Res. 375:1986;172-175.
39. Niznik H.B., Fogel E.F., Fassos F.F., Seeman P. The dopamine transporter is absent in parkinsonian putamen and reduced in the caudate nucleus. J. Neurochem. 56:1991;192-198.
40. Niznik H.B., VanTol H.H.M. Dopamine receptor genes: new tools for molecular psychiatry. J. psychiat. Neurosci. 17:1992;158-179.
41. 4 receptor: sequence, gene, structure and demonstration of expression in the cardiovascular system. The New Biologist. 4:1992;137-146.
42. Parry T.J., Eberle-Wang K., Lucki I., Chesselet M.F. Dopaminergic stimulation of subthalamic nucleus elicits oral dyskinesia in rats. Expl Neurol. 128:1994;181-190.
43. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates, 2nd edn. Academic, New York.
44. Robledo P., Feger J. Excitatory influence of rat subthalamic nucleus to substantia nigra pars reticulata and the pallidal complex: electrophysiological data. Brain Res. 518:1990;47-54.
45. Rosales M.G., Flores G., Hernández S., Martínez-Fong D., Aceves J. Activation of subthalamic neurons produces NMDA receptor-mediated dendritic dopamine release in substantia nigra pars reticulata: a microdialysis study in the rat. Brain Res. 645:1994;335-337.
46. Rosales G., Martínez-Fong D., Morales R., Nuñez A., Flores G., Góngora-Alfaro J.L., Florán B., Aceves J. Reciprocal interaction between glutamate and dopamine in the pars reticulata of the rat substantia nigra: a microdialysis study. Neuroscience. 80:1997;803-810.
47. Sibley D.R., Monsma F.J. Jr. Molecular biology of dopamine receptors. Trends pharmac. Sci. 13:1992;61-69.
48. 2 receptor mRNA in rat brain. Eur. J. Pharmac. 225:1992;143-150.
49. Staunton D.A., Wolfe B.B., Groves P.M., Molinoff P.B. Dopamine receptor changes following destruction of the nigrostriatal pathway: lack of a relationship to rotation behavior. Brain Res. 211:1981;72-74.
50. Versteeg D.H., Gugten J.V., DeLong W., Palkovits M. Regional concentrations of noradrenaline and dopamine in rat brain. Brain Res. 113:1976;563-574.
51. Wechsler L.R., Savaki H.E., Sokoloff L. Effects of D- and L-amphetamine on local cerebral glucose utilization in the conscious rat. J. Neurochem. 32:1979;15-22.
52. 2 dopamine receptor mRNA in rat brain. Proc. natn. Acad. Sci. U.S.A. 88:1991;1859-1863.
53. 1 dopamine receptors. Nature. 347:1990;76-80.